Carobbi A et al. |
Effect of splenectomy in combination with FK 506 and 15-deoxyspergualin on cardiac xenograft survival. |
1991 |
Transplant. Proc. |
pmid:1703704
|
Garcia CD et al. |
Renal transplantation in children less than six years old. |
2001 Nov-Dec |
Transplant. Proc. |
pmid:11750527
|
Smoter P et al. |
Risk factors of acute renal failure after orthotopic liver transplantation: single-center experience. |
2014 |
Transplant. Proc. |
pmid:25380918
|
Mendez R |
FK 506 and mycophenolate mofetil in renal transplant recipients: six-month results of a multicenter, randomized dose ranging trial. FK 506 MMF Dose-Ranging Kidney Transplant Study Group. |
1998 |
Transplant. Proc. |
pmid:9636522
|
Yuan QS et al. |
Rescue therapy with tacrolimus in renal graft patients with cyclosporine A-induced hepatotoxicity: a preliminary study. |
2000 |
Transplant. Proc. |
pmid:11119896
|
Kahl A et al. |
First results with a quadruple therapy regimen including tacrolimus and mycophenolate mofetil in patients after combined pancreas and kidney transplantation. |
1998 |
Transplant. Proc. |
pmid:9532149
|
Sánchez-Fructuoso AI et al. |
The prevalence of uridine diphosphate-glucuronosyltransferase 1A9 (UGT1A9) gene promoter region single-nucleotide polymorphisms T-275A and C-2152T and its influence on mycophenolic acid pharmacokinetics in stable renal transplant patients. |
2009 Jul-Aug |
Transplant. Proc. |
pmid:19715905
|
Asensio M et al. |
Experience with tacrolimus as primary immunosuppressor in pediatric liver transplant. |
2002 |
Transplant. Proc. |
pmid:11959208
|
Brook NR et al. |
Prograf produces a molecular environment favoring antifibrosis, an effect reversed by the addition of rapamune. |
2005 Jan-Feb |
Transplant. Proc. |
pmid:15808577
|
Mueller AR et al. |
Increased rejection after liver transplantation in FK 506-treated patients is associated with viral hepatitis C disease. |
1994 |
Transplant. Proc. |
pmid:7527984
|
Gregory CR et al. |
Effects of treatment with cyclosporine, FK 506, rapamycin, mycophenolic acid, or deoxyspergualin on vascular muscle proliferation in vitro and in vivo. |
1993 |
Transplant. Proc. |
pmid:7679842
|
McMichael J et al. |
Evaluation of a novel "intelligent" dosing system for optimizing FK 506 therapy. |
1991 |
Transplant. Proc. |
pmid:1721275
|
Valdivia LA et al. |
Prolonged survival of hearts obtained from chimeric donors in a mouse to rat xenotransplant model. |
1996 |
Transplant. Proc. |
pmid:8623371
|
Bond MMK et al. |
Cyclosporine Versus Tacrolimus: Which Calcineurin Inhibitor Has Influence on Cytomegalovirus Infection in Cardiac Transplantation? |
2018 |
Transplant. Proc. |
pmid:29661443
|
Nalesnik MA et al. |
The effect of FK 506 and CyA on the Lewis rat renal ischemia model. |
1990 |
Transplant. Proc. |
pmid:1689911
|
Cantarovich M et al. |
Optimal time points for the prediction of the area-under-the-curve in liver transplant patients receiving tacrolimus. |
1998 |
Transplant. Proc. |
pmid:9636592
|
Hachida M et al. |
Combined use of deoxyspergualin and FK 506 for temporary circulatory assist. |
1999 |
Transplant. Proc. |
pmid:10455968
|
Harihara Y et al. |
Correlation between graft size and necessary tacrolimus dose after living-related liver transplantation. |
2000 |
Transplant. Proc. |
pmid:11120116
|
Oishi M et al. |
A case of hyperkalemic distal renal tubular acidosis secondary to tacrolimus in living donor liver transplantation. |
2000 |
Transplant. Proc. |
pmid:11120143
|
van Hooff JP et al. |
Tacrolimus and glucose metabolism. |
1999 |
Transplant. Proc. |
pmid:10576044
|
Soriano S et al. |
Single-center experience with initial intravenous dosing of tacrolimus after kidney transplantation. |
1999 |
Transplant. Proc. |
pmid:10576045
|
Torio A et al. |
Effect of CYP3A51/3 polymorphism on blood pressure in renal transplant recipients. |
2012 |
Transplant. Proc. |
pmid:23146466
|
Yoshimura N et al. |
Combination therapy of tacrolimus (FK506) with azathioprine and steroids in renal transplant recipients. |
1998 |
Transplant. Proc. |
pmid:9474949
|
Kim SJ et al. |
Randomized trial of tacrolimus versus cyclosporine in steroid withdrawal in living donor renal transplant recipients. |
2004 |
Transplant. Proc. |
pmid:15518759
|
Boran M et al. |
Determining renal resistive and pulsatility indexes long-term after kidney transplantation in kidney transplant recipients on cyclosporine a-, tacrolimus-, or sirolimus-based regimens. |
2014 |
Transplant. Proc. |
pmid:24935296
|
Zeevi A et al. |
In vitro assessment of FK 506 immunosuppressive activity in transplant patients. |
1991 |
Transplant. Proc. |
pmid:1721307
|
Woo J et al. |
Effects of FK 506 and low concentration cyclosporine on human lymphocyte activation antigen expression: a flow cytometric analysis. |
1990 |
Transplant. Proc. |
pmid:1697113
|
Laftavi MR et al. |
African American renal transplant recipients (RTR) require higher tacrolimus doses to achieve target levels compared to white RTR: does clotrimazole help? |
2013 |
Transplant. Proc. |
pmid:24314941
|
Falkiewicz K et al. |
Tacrolimus decreases tubular phosphate wasting in renal allograft recipients. |
2003 |
Transplant. Proc. |
pmid:14529892
|
Reggiani P et al. |
A "steroid-free" tacrolimus and low-dose mycophenolate mofetil primary immunosuppression does not prevent early acute rejection after liver transplantation. |
2005 |
Transplant. Proc. |
pmid:15919435
|
Ge J et al. |
Impact of FOXP3 Polymorphisms on the Blood Level of Tacrolimus in Renal Transplant Recipients. |
|
Transplant. Proc. |
pmid:27569929
|
Kapturczak MH et al. |
Pharmacology of calcineurin antagonists. |
2004 |
Transplant. Proc. |
pmid:15041303
|
Yang SS et al. |
A single center, open-label, randomized pilot study to evaluate the safety and efficacy of tacrolimus modified release, Advagraf, versus tacrolimus twice daily, Prograf, in stable renal recipients (single). |
2015 |
Transplant. Proc. |
pmid:25891697
|
Jin KB et al. |
Effects of tacrolimus on antioxidant status and oxidative stress in glioma cells. |
2008 |
Transplant. Proc. |
pmid:18929850
|
Hranjec T et al. |
Benign transient hyperphosphatasemia associated with Epstein-Barr virus enteritis in a pediatric liver transplant patient: a case report. |
2008 |
Transplant. Proc. |
pmid:18589195
|
Grossi P et al. |
Infectious complications in experimental small bowel transplantation. |
1994 |
Transplant. Proc. |
pmid:7518155
|
Tsugita M et al. |
Prevention of sensitization and hyperacute rejection in liver and heart xenografts by FK 506 plus donor antigens. |
1995 |
Transplant. Proc. |
pmid:7533393
|
Takaori K et al. |
Basic study on immunologic effects of cyclosporine and FK 506 for application to pancreatic transplantation. |
1992 |
Transplant. Proc. |
pmid:1376531
|
Ohtsuka S et al. |
The effect of short-term FK 506 therapy on pancreas transplantation using the cuff technique in rats. |
1992 |
Transplant. Proc. |
pmid:1376532
|
Shaw BW et al. |
FK 506 for rescue treatment of acute and chronic rejection in liver allograft recipients. |
1991 |
Transplant. Proc. |
pmid:1721338
|
McDiarmid SV et al. |
FK 506 rescue therapy in liver transplantation: outcome and complications. |
1991 |
Transplant. Proc. |
pmid:1721339
|
Troisi R et al. |
Are reduced tacrolimus dosages needed in the early postoperative period following living donor liver transplantation in adults? |
2002 |
Transplant. Proc. |
pmid:12176470
|
Varo E et al. |
Alternative immunosuppression for acute renal failure in liver transplantation: role of ultra-low dose tacrolimus and basiliximab. |
2002 |
Transplant. Proc. |
pmid:12176471
|
Daoud AJ et al. |
A comparison of the safety and efficacy of mycophenolate mofetil, prednisone and cyclosporine and mycophenolate mofetil, and prednisone and tacrolimus. |
1998 |
Transplant. Proc. |
pmid:9865303
|
Braun F et al. |
How to handle mycophenolate mofetil in combination with tacrolimus? |
1998 |
Transplant. Proc. |
pmid:9865309
|
Zegarska J et al. |
Tacrolimus Metabolite M-III May Have Nephrotoxic and Myelotoxic Effects and Increase the Incidence of Infections in Kidney Transplant Recipients. |
2016 |
Transplant. Proc. |
pmid:27496443
|
Yuan-Xin L et al. |
Preliminary experience with alemtuzumab induction therapy combined with maintenance low-dose tacrolimus monotherapy in small-bowel transplantation in China. |
2010 Jan-Feb |
Transplant. Proc. |
pmid:20172275
|
Colak T et al. |
Effect of conversion from cyclosporine to tacrolimus on lipid profiles in renal transplant recipients. |
2002 |
Transplant. Proc. |
pmid:12270321
|
Woodside KJ et al. |
Conversion from cyclosporine to tacrolimus results in improved creatinine but does not alter lipid profile. |
2005 |
Transplant. Proc. |
pmid:15919491
|
Sánchez-Pérez B et al. |
Influence of immunosuppression and effect of hepatitis C virus on new onset of diabetes mellitus in liver transplant recipients. |
2008 |
Transplant. Proc. |
pmid:19010171
|
Ye Q et al. |
Persistence of donor cells and incidence of graft-versus-host disease after simultaneous small bowel and bone marrow transplantation. |
1996 |
Transplant. Proc. |
pmid:8907895
|
Waller JR et al. |
Primary immunosuppression with tacrolimus is associated with a reduction in renal allograft fibrosis compared with neoral therapy. |
2002 |
Transplant. Proc. |
pmid:12176496
|
Ribes D et al. |
Combined use of tacrolimus and sirolimus in de novo renal transplant patients: current data. |
2005 Jul-Aug |
Transplant. Proc. |
pmid:16182816
|
Wijnen RM et al. |
Toxicity of FK 506 in the cynomolgus monkey: noncorrelation with FK 506 serum levels. |
1991 |
Transplant. Proc. |
pmid:1721371
|
Venkataramanan R et al. |
Pharmacokinetics of FK 506 following oral administration: a comparison of FK 506 and cyclosporine. |
1991 |
Transplant. Proc. |
pmid:1703355
|
Hattori R et al. |
FK 506 in cadaveric kidney transplantation from non-heart-beating donors. |
1998 |
Transplant. Proc. |
pmid:9838666
|
Fischer L et al. |
Hepatitis G virus infection in liver transplant recipients. |
1999 Feb-Mar |
Transplant. Proc. |
pmid:10083208
|
Goller AL et al. |
Loss of serum bicarbonate after discordant liver xenotransplantation. |
2000 |
Transplant. Proc. |
pmid:10936383
|
Scott-Douglas N et al. |
Treatment of acute renal transplant rejection with FK 506 in patients on cyclosporine after failure of standard antirejection therapy. |
1996 |
Transplant. Proc. |
pmid:8962226
|
Boots JM et al. |
Early steroid withdrawal in renal transplantation with tacrolimus dual therapy: a pilot study. |
2002 |
Transplant. Proc. |
pmid:12176542
|
Citterio F et al. |
Steroid withdrawal from tacrolimus-based therapy in renal transplant patients. |
2002 |
Transplant. Proc. |
pmid:12176545
|
Cho JH et al. |
Impact of cytochrome P450 3A and ATP-binding cassette subfamily B member 1 polymorphisms on tacrolimus dose-adjusted trough concentrations among Korean renal transplant recipients. |
2012 |
Transplant. Proc. |
pmid:22310591
|
Suzuki H et al. |
Spleen grafting might induce transplantation tolerance in rats. |
1995 |
Transplant. Proc. |
pmid:7536973
|
Ji SM et al. |
Conversion from cyclosporine to tacrolimus for chronic allograft nephropathy. |
2007 |
Transplant. Proc. |
pmid:17580148
|
Morrisett JD et al. |
Effect of FK 506 and cyclosporine on plasma cholesterol levels in rabbits. |
1991 |
Transplant. Proc. |
pmid:1721402
|
Kobayashi N et al. |
Abdominal organ cluster transplantation in pigs receiving FK 506. |
1992 |
Transplant. Proc. |
pmid:1379754
|
Kuroki H et al. |
Experimental studies of vascularized allogeneic limb transplantation in the rat using a new immunosuppressive agent, FK-506: morphological and immunological analysis. |
1989 |
Transplant. Proc. |
pmid:2468255
|
Opelz G |
New immunosuppressants and HLA matching. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11266911
|
Fu F et al. |
Systemic administration of CTLA4-Ig or anti-CD40 ligand antibody inhibits second-set rejection of mouse liver allografts. |
1999 Feb-Mar |
Transplant. Proc. |
pmid:10083555
|
Tatekawa Y et al. |
Intragraft expression of p38 in rat small bowel transplantation. |
2000 |
Transplant. Proc. |
pmid:10995948
|
Karamperis N et al. |
Comparison of the pharmacokinetics of tacrolimus and cyclosporine at equivalent molecular doses. |
2003 |
Transplant. Proc. |
pmid:12826146
|
Budde K et al. |
Long-term outcome of tacrolimus rescue therapy in late rejection after renal transplantation. |
1998 |
Transplant. Proc. |
pmid:9723280
|
Dopazo C et al. |
Severe rhabdomyolysis and acute renal failure secondary to concomitant use of simvastatin with rapamycin plus tacrolimus in liver transplant patient. |
2009 |
Transplant. Proc. |
pmid:19376416
|
Baran DA et al. |
Can initial tacrolimus trough levels be predicted from clinical variables? |
2004 |
Transplant. Proc. |
pmid:15621157
|
Land W et al. |
Tacrolimus versus cyclosporine in primary simultaneous pancreas-kidney transplantation: preliminary results at 1 year of a large multicenter trial. |
2002 |
Transplant. Proc. |
pmid:12176625
|
El-Safa EA et al. |
Paradoxical response to tacrolimus assessed by interleukin-2 gene expression. |
2006 |
Transplant. Proc. |
pmid:17175263
|
Hayakawa K et al. |
Maintenance of unresponsiveness by short-term pulse therapy with FK 506 in rat transplantation. |
1996 |
Transplant. Proc. |
pmid:8658904
|
Moura Neto A et al. |
Frequency of Thyroid Dysfunction in Patients With Diabetes Mellitus Before and After Liver Transplantation. |
2018 |
Transplant. Proc. |
pmid:29661439
|
Wu GD et al. |
FK 506 inhibits the development of transplant arteriosclerosis. |
1991 |
Transplant. Proc. |
pmid:1721433
|
Kobayashi N et al. |
Effect of FK 506 on abdominal organ cluster transplantation in pigs. |
1991 |
Transplant. Proc. |
pmid:1721434
|
Todo S et al. |
Canine kidney transplantation with FK-506 alone or in combination with cyclosporine and steroids. |
1987 |
Transplant. Proc. |
pmid:2445076
|
Wada H et al. |
An attempt to induce tolerance to skin grafts in congenic mice with FK 506. |
1991 |
Transplant. Proc. |
pmid:1721435
|
Collier DS et al. |
Kidney transplantation in the dog receiving FK-506. |
1987 |
Transplant. Proc. |
pmid:2445077
|
Calne R et al. |
Observations about FK-506 in primates. |
1987 |
Transplant. Proc. |
pmid:2445078
|
Sperschneider H |
A large, multicentre trial to compare the efficacy and safety of tacrolimus with cyclosporine microemulsion following renal transplantation. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267291
|
Mühlbacher F |
Tacrolimus versus cyclosporin microemulsion in liver transplantation: results of a 3-month study. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267317
|
Shapiro R |
Tacrolimus in solid organ transplantation: an update. |
1999 |
Transplant. Proc. |
pmid:10500545
|
Duzova A et al. |
Triple immunosuppression with or without basiliximab in pediatric renal transplantation: acute rejection rates at one year. |
2003 |
Transplant. Proc. |
pmid:14697926
|
Morales E et al. |
Conversion from cyclosporine to FK 506 as rescue therapy in renal transplantation with poorly steroid-responsive acute rejection. |
1999 |
Transplant. Proc. |
pmid:10500562
|
Martins L et al. |
Conversion to tacrolimus in case-problem kidney transplant recipients under cyclosporine-based immunosuppression. |
2000 |
Transplant. Proc. |
pmid:11134735
|
Nardo B et al. |
Evidence of microchimerism after pretransplant blood transfusion and FK 506 in liver xenograft. |
2000 |
Transplant. Proc. |
pmid:11134771
|
Fritsche L et al. |
Late conversion to mycophenolate mofetil for chronic deterioration of renal allograft function. |
1998 |
Transplant. Proc. |
pmid:9723451
|
Fornairon S et al. |
Can we improve the results of simultaneous pancreas-kidney transplantation? |
1998 |
Transplant. Proc. |
pmid:9745580
|
Hanack U et al. |
Is there a different impact of cyclosporine versus tacrolimus on delayed graft function after kidney transplantation? |
1998 |
Transplant. Proc. |
pmid:9723477
|
Miyata Y et al. |
Development of xenogeneic microchimerism correlated with graft outcome in hamster-to-rat heart xenotransplantation. |
1998 |
Transplant. Proc. |
pmid:9723548
|
Mohsin N et al. |
Low tacrolimus dose requirements in renal transplant recipients in the omani population: implications for pharmacogenetics? |
2005 |
Transplant. Proc. |
pmid:16213259
|
Lee CM et al. |
Monotherapy with tacrolimus for heart and liver transplant: a case report. |
2014 |
Transplant. Proc. |
pmid:24767396
|
Lo A et al. |
Ganciclovir prophylaxis for cytomegalovirus infection in simultaneous kidney-pancreas transplant recipients receiving tacrolimus, mycophenolate mofetil, and prednisone. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267516
|
Malinowski K et al. |
Effect of different anti-rejection regimens on the expression of differentiation and activation markers on the surface of host lymphocytes. |
2000 |
Transplant. Proc. |
pmid:10856579
|
Matsumoto S et al. |
ET-Kyoto ductal injection and density-adjusted purification combined with potent anti-inflammatory strategy facilitated single-donor islet transplantation: case reports. |
2010 Jul-Aug |
Transplant. Proc. |
pmid:20692433
|